AU2002226048A1 - Urotensin-ii receptor antagonists - Google Patents
Urotensin-ii receptor antagonistsInfo
- Publication number
- AU2002226048A1 AU2002226048A1 AU2002226048A AU2604802A AU2002226048A1 AU 2002226048 A1 AU2002226048 A1 AU 2002226048A1 AU 2002226048 A AU2002226048 A AU 2002226048A AU 2604802 A AU2604802 A AU 2604802A AU 2002226048 A1 AU2002226048 A1 AU 2002226048A1
- Authority
- AU
- Australia
- Prior art keywords
- urotensin
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000012327 Urotensin II receptors Human genes 0.000 title 1
- 108050002984 Urotensin II receptors Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25460000P | 2000-12-11 | 2000-12-11 | |
US60254600 | 2000-12-11 | ||
PCT/US2001/047451 WO2002047687A1 (en) | 2000-12-11 | 2001-12-05 | Urotensin-ii receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002226048A1 true AU2002226048A1 (en) | 2002-06-24 |
Family
ID=22964900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002226048A Abandoned AU2002226048A1 (en) | 2000-12-11 | 2001-12-05 | Urotensin-ii receptor antagonists |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040039017A1 (en) |
EP (1) | EP1351688A4 (en) |
JP (1) | JP2004515530A (en) |
AU (1) | AU2002226048A1 (en) |
WO (1) | WO2002047687A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1499607T3 (en) | 2001-12-04 | 2006-04-18 | Actelion Pharmaceuticals Ltd | 4- (piperidyl and pyrrolidyl-alkyl-ureido) quinolines as urotensin II receptor antagonists |
JP4559230B2 (en) * | 2002-11-28 | 2010-10-06 | スベン ライフ サイエンシズ リミティド | Novel N-arylsulfonyl-3-substituted indoles having affinity for serotonin receptors, methods for their preparation, and pharmaceutical compositions containing them |
KR20070014108A (en) | 2003-09-26 | 2007-01-31 | 액테리온 파마슈티칼 리미티드 | Pyridine derivatives and use thereof as urotensin ii antagonists |
WO2005040163A1 (en) * | 2003-10-28 | 2005-05-06 | Dr. Reddy's Laboratories Ltd | Heterocyclic compounds that block the effects of advanced glycation end products (age) |
BRPI0515979A (en) | 2004-10-12 | 2008-08-12 | Actelion Pharmaceuticals Ltd | compound, process for preparing same, compositions, use of one or more compounds, and method of treating a patient suffering from a disorder |
TW200804347A (en) * | 2006-01-10 | 2008-01-16 | Janssen Pharmaceutica Nv | Urotensin II receptor antagonists |
CL2007002097A1 (en) * | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compounds derived from pyrrolidine or morpholine antagonists of urotensin ii; pharmaceutical composition comprising said compounds; and its use to treat congestive heart failure, ischemic heart failure, angina, myocardial ischemia, overactive bladder, asthma and / or copd, among others. |
AU2007281591A1 (en) | 2006-07-31 | 2008-02-07 | Janssen Pharmaceutica, N.V. | Urotensin II receptor antagonists |
EP2155748A1 (en) * | 2007-05-15 | 2010-02-24 | Boehringer Ingelheim International GmbH | Urotensin ii receptor antagonists |
EP2326644B1 (en) | 2008-08-02 | 2012-02-22 | Janssen Pharmaceutica N.V. | Urotensin ii receptor antagonists |
JOP20180131B1 (en) * | 2018-12-24 | 2023-03-28 | Univ Of Petra | Substituted quinolone compounds, their use in the treatment of cancer, and a method for preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6075137A (en) * | 1998-01-09 | 2000-06-13 | Smithkline Beecham Corporation | Human urotensin II |
CA2330564A1 (en) * | 1998-04-29 | 1999-11-04 | John Stephen Elder | Quinolones used as mrs inhibitors and bactericides |
US20040053963A1 (en) * | 2000-12-11 | 2004-03-18 | Dashyant Dhanak | Urotensin-II receptor antagonists |
-
2001
- 2001-12-05 EP EP01995470A patent/EP1351688A4/en not_active Withdrawn
- 2001-12-05 US US10/450,106 patent/US20040039017A1/en not_active Abandoned
- 2001-12-05 AU AU2002226048A patent/AU2002226048A1/en not_active Abandoned
- 2001-12-05 JP JP2002549258A patent/JP2004515530A/en not_active Withdrawn
- 2001-12-05 WO PCT/US2001/047451 patent/WO2002047687A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002047687A1 (en) | 2002-06-20 |
US20040039017A1 (en) | 2004-02-26 |
EP1351688A1 (en) | 2003-10-15 |
EP1351688A4 (en) | 2006-01-04 |
JP2004515530A (en) | 2004-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001255798A1 (en) | Glucagon antagonists | |
AU6690001A (en) | Thrombin receptor antagonists | |
AU2002341834A1 (en) | Antagonists | |
AU2001269876A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
AU2001264657A1 (en) | Crf receptor antagonists | |
AU2001234741A1 (en) | Integrin antagonists | |
AU2441801A (en) | Urotensin-ii receptor antagonists | |
AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
AU2001290772A1 (en) | Alpha v integrin receptor antagonists | |
EP1359915A4 (en) | Urotensin-ii receptor antagonists | |
AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
AU2001240021A1 (en) | Diazafluorenone il-8 receptor antagonists | |
AU2001245724A1 (en) | Il-8 receptor antagonists | |
AU6990000A (en) | Novel integrin receptor antagonists | |
AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
AU2002216079A1 (en) | Bombesin receptor antagonists | |
AU2001243351A1 (en) | Il-8 receptor antagonists | |
AU2001263288A1 (en) | Crf receptor antagonists | |
AU2002359524A1 (en) | P2x7 receptor antagonists | |
AU2002217095A1 (en) | Bombesin receptor antagonists | |
AU2001249573A1 (en) | Chemokine receptor antagonists | |
AU2001241896A1 (en) | Il-8 receptor antagonists | |
AU2001253172A1 (en) | Il-8 receptor antagonists | |
AU2001271018A1 (en) | Gpr14 antagonist |